These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 29279527)
1. Impact of Water- and Lipid-Soluble Statins on Nonculprit Lesions in Patients with Acute Coronary Syndrome. Ishikawa Y; Itoh T; Satoh M; Fusazaki T; Sugawara S; Nakajima S; Nakamura M; Morino Y Int Heart J; 2018 Jan; 59(1):27-34. PubMed ID: 29279527 [TBL] [Abstract][Full Text] [Related]
2. Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study). Otagiri K; Tsutsui H; Kumazaki S; Miyashita Y; Aizawa K; Koshikawa M; Kasai H; Izawa A; Tomita T; Koyama J; Ikeda U Circ J; 2011; 75(3):633-41. PubMed ID: 21266787 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Rosuvastatin Versus Atorvastatin for Coronary Plaque Stabilization. Thondapu V; Kurihara O; Yonetsu T; Russo M; Kim HO; Lee H; Soeda T; Minami Y; Jang IK Am J Cardiol; 2019 May; 123(10):1565-1571. PubMed ID: 30851941 [TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial). Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)-rationale and design. Watanabe T; Miyamoto T; Miyasita T; Shishido T; Arimoto T; Takahashi H; Nishiyama S; Hirono O; Matsui M; Sugawara S; Ikeno E; Miyawaki H; Akira F; Kubota I J Cardiol; 2014 Sep; 64(3):236-9. PubMed ID: 24503140 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial). Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S; Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069 [TBL] [Abstract][Full Text] [Related]
7. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial. Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H; J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723 [TBL] [Abstract][Full Text] [Related]
8. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. Hattori K; Ozaki Y; Ismail TF; Okumura M; Naruse H; Kan S; Ishikawa M; Kawai T; Ohta M; Kawai H; Hashimoto T; Takagi Y; Ishii J; Serruys PW; Narula J JACC Cardiovasc Imaging; 2012 Feb; 5(2):169-77. PubMed ID: 22340823 [TBL] [Abstract][Full Text] [Related]
9. Is age an important factor for vascular response to statin therapy? A serial optical coherence tomography and intravascular ultrasound study. Dai J; Hou J; Xing L; Jia H; Hu S; Soeda T; Minami Y; Ong D; Vergallo R; Zhang S; Lee H; Yu B; Jang IK Coron Artery Dis; 2017 May; 28(3):209-217. PubMed ID: 28059849 [TBL] [Abstract][Full Text] [Related]
10. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M; J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026 [TBL] [Abstract][Full Text] [Related]
11. Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study. Kashiyama K; Sonoda S; Muraoka Y; Suzuki Y; Kamezaki F; Tsuda Y; Araki M; Tamura M; Takeuchi M; Abe H; Okazaki M; Fujino Y; Otsuji Y Int J Cardiovasc Imaging; 2015 Jun; 31(5):935-45. PubMed ID: 25724567 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis comparing the effects of rosuvastatin versus atorvastatin on regression of coronary atherosclerotic plaques. Qian C; Wei B; Ding J; Wu H; Cai X; Li B; Wang Y Am J Cardiol; 2015 Nov; 116(10):1521-6. PubMed ID: 26385518 [TBL] [Abstract][Full Text] [Related]
15. The different association of epicardial fat with coronary plaque in patients with acute coronary syndrome and patients with stable angina pectoris: analysis using integrated backscatter intravascular ultrasound. Harada K; Harada K; Uetani T; Kataoka T; Takeshita M; Kunimura A; Takayama Y; Shinoda N; Kato B; Kato M; Marui N; Ishii H; Matsubara T; Amano T; Murohara T Atherosclerosis; 2014 Oct; 236(2):301-6. PubMed ID: 25117765 [TBL] [Abstract][Full Text] [Related]
16. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study. Ohashi T; Shibata R; Morimoto T; Kanashiro M; Ishii H; Ichimiya S; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura T; Daida H; Murohara T; Matsuzaki M Atherosclerosis; 2010 Sep; 212(1):237-42. PubMed ID: 20684825 [TBL] [Abstract][Full Text] [Related]
17. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study. Miyauchi K; Daida H; Morimoto T; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Kadota K; Kimura K; Hirayama A; Kimura K; Hasegawa Y; Uchiyama S; Matsuzaki M; Circ J; 2012; 76(4):825-32. PubMed ID: 22451449 [TBL] [Abstract][Full Text] [Related]
18. Impact of the triglyceride level on coronary plaque components in female patients with coronary artery disease treated with statins. Yamashita M; Iwata A; Kato Y; Futami M; Imaizumi S; Kuwano T; Ike A; Sugihara M; Nishikawa H; Zhang B; Yasunaga S; Saku K; Miura SI Heart Vessels; 2018 Oct; 33(10):1175-1184. PubMed ID: 29696358 [TBL] [Abstract][Full Text] [Related]
19. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073 [TBL] [Abstract][Full Text] [Related]
20. Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study. Park SJ; Kang SJ; Ahn JM; Chang M; Yun SC; Roh JH; Lee PH; Park HW; Yoon SH; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Han KH; Park SW J Am Coll Cardiol; 2016 Apr; 67(15):1772-1783. PubMed ID: 27081016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]